4 reports

  • CLINICAL TRIAL PROFILE SNAPSHOTS

## ## ## ## ## ## MyoKardia Inc ## ## ## ## ## ## Heart Metabolics Ltd ## ## ## ## ## ## Quintiles IMS Holdings Inc ## ## ## ## ## ## Physicians' Services Incorporated Foundation ## ## ## ## ## ## Novartis AG ## ## ## ## ## ## Katak

  • Cardiovascular Disease
  • Hospital
  • World
  • Product Initiative
  • MyoKardia, Inc.
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

## ## ## ## ## ## ## ## China ## ## ## ## ## ## ## ## India ## ## ## ## ## ## ## ## Russia ## ## ## ## ## ## ## ## Turkey ## ## ## ## ## ## ## ## Mexico Source: GlobalData' s Pharma Intelligence Center Clinical Trials Database (*)Trials are tak

  • Cardiology
  • Cardiovascular Disease
  • Clinical Trial
  • Hospital
  • MyoKardia, Inc.
  • AUG 23, 2018: NEW INSIGHTS ON DISEASE BURDEN FOR HYPERTROPHIC CARDIOMYOPATHY PATIENTS PUBLISHED IN CIRCULATION
  • FEB 01, 2017: MYOKARDIA ANNOUNCES APPOINTMENT OF JUNE LEE, M.D., AS CHIEF OPERATING OFFICER AND RADHIKA TRIPURANENI, M.D., AS VICE PRESIDENT, MEDICAL AFFAIRS

SHE DID HER SURGICAL INTERNSHIP AT BETH ISRAEL DEACONESS MEDICAL CENTER IN BOSTON, A MAJOR TEACHING HOSPITAL OF HARVARD MEDICAL SCHOOL.

  • Cardiovascular Disease
  • Hospital
  • Pharmaceutical
  • United States
  • MyoKardia, Inc.
  • AUG 23, 2018: NEW INSIGHTS ON DISEASE BURDEN FOR HYPERTROPHIC CARDIOMYOPATHY PATIENTS PUBLISHED IN CIRCULATION
  • FEB 01, 2017: MYOKARDIA ANNOUNCES APPOINTMENT OF JUNE LEE, M.D., AS CHIEF OPERATING OFFICER AND RADHIKA TRIPURANENI, M.D., AS VICE PRESIDENT, MEDICAL AFFAIRS

HCM-##, DCM-## AND LUS-## ARE BEING EVALUATED IN PRECLINICAL PHASE.

  • Cardiovascular Disease
  • Hospital
  • United States
  • Company Financials
  • MyoKardia, Inc.